Further experiments showed that DExH-Box Helicase 9 regulates the AKT signaling pathway, and animal studies confirmed that DExH-Box Helicase 9 knockdown inhibits hepatocellular carcinoma growth, whereas its overexpression reduces Haprolid’s efficacy. Here, AKT1 is linked to hepatocellular carcinoma.